Clinical Trials on Marionette Lines in Canada
Total 30 results
-
Revance Therapeutics, Inc.CompletedGlabellar Frown LinesCanada
-
Medy-ToxCompletedLateral Canthal Lines | Glabellar LinesUnited States, Germany, Canada
-
Revance Therapeutics, Inc.CompletedUpper Facial Lines (Glabellar Lines, Forehead Lines, & Lateral Canthal Lines)United States, Canada
-
Medy-ToxCompletedLateral Canthal Lines | Glabellar LinesUnited States, Germany, Canada, United Kingdom
-
Revance Therapeutics, Inc.CompletedFrown LinesUnited States, Canada
-
Medy-ToxCompletedLateral Canthal Lines | Glabellar LinesUnited States, Russian Federation, Germany, Canada, Belgium, United Kingdom
-
AllerganCompletedGlabellar Lines | Crow's Feet Lines | Facial RhytidesGermany, Canada, United States, France
-
AllerganCompletedGlabellar Lines | Crow's Feet Lines | Facial RhytidesGermany, Canada, United States, France
-
Galderma R&DCompletedGlabellar Frown Lines (GL) | Lateral Canthal Lines (LCL)United States, Canada
-
Croma-Pharma GmbHHugelCompletedFrown LinesUnited States, Austria, Canada
-
AllerganCompleted
-
AllerganCompletedCrow's Feet Lines | Lateral Canthus RhytidesBelgium, Canada, United States, United Kingdom
-
AllerganCompletedGlabellar Frown Lines | Facial RhytidesCanada
-
Galderma R&DCompletedLateral Canthal LinesUnited States, Canada
-
Galderma R&DCompletedGlabellar Frown LinesUnited States, Canada
-
Revance Therapeutics, Inc.CompletedEfficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar LinesGlabellar Frown LinesUnited States, Canada
-
Merz Pharmaceuticals GmbHCompletedGlabellar LinesUnited States, Germany, Canada
-
Merz Pharmaceuticals GmbHCompletedModerate to Severe Glabellar Frown LinesUnited States, Canada
-
AbbVieCompletedGlabellar LinesUnited States, Canada, Germany, Hungary, Poland
-
AllerganCompletedGlabellar LinesUnited States, Canada, Brazil, France, Australia
-
Revance Therapeutics, Inc.CompletedGlabellar Frown LinesUnited States, Canada
-
University of British ColumbiaCompletedCentral Line ComplicationCanada
-
Lawson Health Research InstituteUniversity of Western Ontario, CanadaCompletedCentral Line ComplicationCanada
-
AbbVieRecruiting
-
Queen's UniversityUniversity of TorontoCompletedDiastasis Recti And Weakness Of The Linea AlbaCanada
-
Aduro Biotech, Inc.Johns Hopkins UniversityCompleted2nd-line, 3rd-line and Greater Metastatic Pancreatic CancerUnited States, Canada
-
Novartis PharmaceuticalsCompleted3rd Line GISTFrance, United Kingdom, Belgium, Canada, Spain, Netherlands, Japan, United States
-
Fraser HealthSterileCare Inc.; Center for Health Evaluation & Outcome ServicesRecruitingCentral Venous Catheter Thrombosis | Catheter Infection | Catheter Complications | Catheter | Catheter Blockage | Catheter Dysfunction | Central Line-associated Bloodstream Infection (CLABSI) | Central Venous Catheter Related Bloodstream InfectionCanada
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedFirst Line Non-Small Cell Lung CancerSpain, United States, Hungary, Israel, China, Korea, Republic of, Taiwan, Czechia, Russian Federation, Australia, Brazil, Lebanon, Serbia, Thailand, Canada, Slovakia, Ukraine, Bulgaria, Italy, Netherlands, New Zealand, Poland, Belgium, Turk... and more
-
AstraZenecaMerck Sharp & Dohme LLC; GOG Foundation; Myriad Genetic Laboratories, Inc.Active, not recruitingAdvanced Ovarian Cancer | Newly Diagnosed | FIGO Stage III-IV | Partial Response | Complete Response | BRCA Mutation | First Line Platinum ChemotherapyKorea, Republic of, France, Italy, United States, Israel, Canada, China, Brazil, United Kingdom, Poland, Australia, Japan, Netherlands, Russian Federation, Spain